Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis
Clinical trial NCT05630872 · COMPLETED
Trial details
- NCT number
- NCT05630872
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-13
- Primary completion
- 2025-05-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.